In a heartening move, Bihar's health minister shared that seven young patients battling thalassaemia have embarked on a ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Artiva Biotherapeutics is developing NK cell immunotherapy for autoimmune disease. Early trial data in B-cell lymphoma ...
Seven years after the activation of the prostate biopsy service using Fusion technology, one of the most advanced innovations ...
Lung cancer varies widely from patient to patient, and that diversity makes it hard to find effective treatments. Researchers ...
Club Golf on MSN
Senior PGA Tour pro speaks honestly after cancer diagnosis: "It hit me like a truck"
For men after 50, regular medical tests, including PSA (prostate-specific antigen), are a necessity. And that’s what saved ...
Patients will be able to access video consultations with specialists around the country for prostate, menopause or eyesight problems through new NHS Online hospitals ...
MELBOURNE, Australia and INDIANAPOLIS, Jan. 16, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
The University of Cambridge is developing a blood test that could detect a common cancer that kills 12,000 people each year.
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
NHS Scotland has approved a one-time CRISPR gene therapy for severe sickle cell disease, offering durable reduction in vaso-occlusive crises for eligible patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results